Is a complete BBOT research report available?

No complete published report is available for BridgeBio Oncology Therapeutics, Inc. (BBOT) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

BridgeBio Oncology Therapeutics, Inc. (BBOT)

NASDAQ: BBOT · USD

$8.50

+0.26 (+3.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BBOT analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	680.9M
Net income (ttm)	-154.1M
EPS (ttm)	-$3.02
Shares out	80.1M
Volume	293,362
Beta	0.39
Price target	$25.3	+197.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -154.1M
EPS (ttm): -$3.02
Market cap: 680.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All BBOT indicators

Market & fundamental data

Available fields

169

Groups with data

Currency

USD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001869105
Company name	BridgeBio Oncology Therapeutics, Inc.
Country	United States
Country code	US
Cusip	107924102
Employees	106
Employees Change	14%
Employees Change Percent	15.22
Enterprise value	$294.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US1079241022
Last refreshed	2026-07-31
Market cap	$680.9M
Market cap category	Small-Cap
Price	$8.5
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Symbol	BBOT
Website	https://bbotx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-22.63%
FCF yield	-19.19%
P/B ratio	1.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-154.1M
Net Income Growth Years	0%
Profit Per Employee	$-1.5M
ROA	-37.2
ROCE	-37.37
ROE	-62.21
ROIC	-42.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-20.8%
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$417.6M
Cash	$252.3M
Current Assets	$266.5M
Current Liabilities	$43.3M
Debt	$2.6M
Debt Equity	$0.01
Equity	$372.3M
Liabilities	$45.4M
Long Term Assets	$151.1M
Long Term Liabilities	$2.1M
Net Cash	$386.2M
Net Cash By Market Cap	$56.73
Net Cash Growth	190.26%
Net Debt Equity	$-1.04
Tangible Book Value	$372.3M
Tangible Book Value Per Share	$4.65
WACC	6.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.16
Net Working Capital	$-28.5M
Quick ratio	5.83
Working Capital	$223.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-61,110.88%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-20.78%
200-day SMA	10.15
50-day SMA	8.23
50-day SMA vs 200-day SMA	50under200
All Time High	14.87
All Time High Change	-42.84%
All Time High Date	2025-12-08
All Time Low	7
All Time Low Change	21.43%
All Time Low Date	2026-06-11
ATR	0.56
Beta	0.39
Beta1y	0.8
Beta2y	0.23
Ch YTD	-32.11
High	8.65
High52	14.87
High52 Date	2025-12-08
High52ch	-42.84%
Low	8.1
Low52	7
Low52 Date	2026-06-11
Low52ch	21.43%
Ma50ch	3.32%
Price vs 200-day SMA	-16.23%
RSI	51.32
RSI Monthly	39.6
RSI Weekly	45
Sharpe ratio	-0.05x
Sortino ratio	0
Total Return	-61,110.88%
Tr YTD	-32.11
Tr1m	10.97%
Tr1w	-2.52%
Tr3m	5.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	11
Analyst Count Top	6
Analyst Price Target Top	$26.17
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.54
Operating Income	$-168.9M
Price target	$25.3
Price Target Change	$198
Price Target Change Top	$208

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	35,744,870%
Float Percent	44.62%
Shares Insiders	0.02%
Shares Institutions	40.25%
Shares Out	80,107,104
Shares Qo Q	0.06%
Shares Yo Y	61,110.88%
Short Float	15.91%
Short Ratio	9.75
Short Shares	7.1

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-139.8M
Adjusted OCF	-139,329,000
Average Volume	355,427.25x
Bv Per Share	4.65
CAPEX	$-468,000
Ch1m	10.97
Ch1w	-2.52
Ch1y	-20.78
Ch3m	5.46
Ch6m	-32
Change	3.16%
Change From Open	2.78
Close	8.24
Days Gap	0.36
Depreciation Amortization	300,000
Dollar Volume	2,493,577
Earnings Date	2026-08-26
Earnings Time	bmo
EBIT	$-139.9M
EBITDA	$-139.9M
EPS	$-3.02
F Score	2
FCF	$-130.7M
FCF EV Yield	-44.35x
FCF Per Share	$-1.63
Financing CF	384,101,000
Fiscal Year End	December
Founded	2,016
Investing CF	-227,447,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Type	Never
Ma150	9.5
Ma150ch	-10.56%
Ma20	8.58
Ma20ch	-0.89%
Net CF	26,442,000
Next Earnings Date	2026-08-26
Open	8.27
Optionable	No
Position In Range	72.73
Post Close	8.5
Postmarket Change Percent	0.41
Postmarket Price	$8.53
Ppne	3,156,000
Price Date	2026-07-30
Ptbv Ratio	1.83
Relative Volume	0.83x
Share Based Comp	9,117,000
Tr6m	-32%
Us State	California
Volume	293,362

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Coverage state: Market snapshot only — no published research

Generate the first BBOT analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · BBOT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BBOT indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BBOT

Frequently asked questions